Condition: Factor VIII Deficiency · Sponsor: Sanofi
The objective of the study is to assess the improvement of synovial hypertrophy during the 12 months of efanesoctocog alfa prophylaxis once per week (QW) in joints with existing evidence of synovial hypertrophy in participants with hemophilia A. The study duration for each participant is approximately 12 months.
This description comes directly from the study's public registry record.
Trial Transparency email recommended (Toll free for US & Canada) · 800-633-1610 · Contact-US@sanofi.com
Always discuss trial participation with your own doctor first.
| Orthopedic Institute for Children- Site Number : 8400009 | Los Angeles, California, United States | Recruiting |
| Innovative Hematology, Inc.- Site Number : 8400006 | Indianapolis, Indiana, United States | Recruiting |
| University of Iowa- Site Number : 8400004 | Iowa City, Iowa, United States | Recruiting |
| Ohio State University Hospital East- Site Number : 8400001 | Columbus, Ohio, United States | Recruiting |
| Investigational Site Number : 1240003 | Hamilton, Ontario, Canada | Recruiting |
| Investigational Site Number : 1240004 | Hamilton, Ontario, Canada | Recruiting |
| Investigational Site Number : 3920003 | Kawasaki, Kanagawa, Japan | Recruiting |
| Investigational Site Number : 3920002 | Hiroshima, Japan | Recruiting |
| Investigational Site Number : 3920001 | Saitama, Japan | Recruiting |
| Investigational Site Number : 3920004 | Tokyo, Japan | Recruiting |
| Investigational Site Number : 1580003 | Kaohsiung City, Taiwan | Recruiting |
| Investigational Site Number : 1580001 | Taichung, Taiwan | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06941870